At Johnson Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/. 

For more than 130 years, diversity, equity inclusion (DEI) has been a part of our cultural fabric at Johnson Johnson and woven into how we do business every day. Rooted in Our Credo, the values of DEI fuel our pursuit to create a healthier, more equitable world. Our diverse workforce and culture of belonging accelerate innovation to solve the world’s most pressing healthcare challenges.

We know that the success of our business – and our ability to deliver meaningful solutions – depends on how well we understand and meet the diverse needs of the communities we serve. Which is why we foster a culture of inclusion and belonging where all perspectives, abilities and experiences are valued and our people can reach their potential.

At Johnson Johnson, we all belong.

To maximize company product value through high scientific quality communication with Leading Specialists on a peer-to-peer basis. Accordingly, to strategic lines of Medical Affairs Plan, the MSL is jointly responsible for achieving short-term and long-term company goals at local level.

To be a therapeutic area scientific expert, responsible for discussing our products, patients’ treatment trends and studies in the therapeutic areas in which we are involved, on a peer-to-peer basis with a defined audience of Leading Specialists (Physicians, Pharmacists, Hospital Managers, Board Members of Scientific Societies, and other stakeholders) and to be consideredan internal and external trusted scientific counterpart.

MSLs should have their own Activity Plan and personal objectives. The Individual Activity Plans must be based on the MSLs Country Activity Plan, which is aligned with the Medical Affairs Component of the relevant Brand Plans

To keep abreast ofmedical and scientific knowledge.Continuous update on products, patient’s treatment trends, clinical activities and studies conducted within the therapeutic area in their region.Development and maintenance of acontact network with Leading Specialists.Understand their needs, key value drivers, practical treatment patterns and scientific activities within therapeutic areaCommunicate value of company products, incl. clinical questionnaire discussionsThrough scientific interactions, communicate medical benefits of products and contribute to foster innovative approachesRepresent the company within professional associations in the therapeutic area in cooperation with Medical Affairs/ Medical Education and other positions in the Medical Affairs Department.Proactive and reactive communication of medical scientific data according to following criteriaProactive Scientific Communication to Leading Specialists must be consistent with the last approved Summary of Product Characteristics regarding the safe and effective use of approved products in approved indications. Content of Scientific Communication should be highly scientific, accurate, fair and objective, based on an up-to-date evaluation of all relevant evidence and reflect that evidence clearly, using neither marketing claims nor brand name.In some very specific circumstances, the MSL can interact proactively with non-Leading Specialists. The program should be clearly defined in the MSL Country Activity Plan, providing the rational, the objective, content, timelines and selection criteria of the HCPs to be involved.Description of RD programs and discussing regulatory developments with no promotional intent are also part of Scientific Communication.Reactive Communication of medical scientific data can be provided upon request to any Health Care Professional, within the approved label or off-label. The request should come either directly from the HCP or via the Medical Information department. MSLs are required to document all off-label information requests they receive from Leading Specialists and other HCPs that they may interact withOrganization and participation inMedical Education activities,at local /regional level:Identify/support/educate speakersBuild Medical Education programs with scientific third partyCollaborate with Medical Education manager in National Medical education activitiesProvide scientific material under request. MSLs may initiate discussion with potential speakers, discussing documents/ slides which may be of help for future presentations.Organization and participation inAdvisory Boards in cooperation with Medical Affairs/Medical Education/other positions in the Medical Affairs Department.Market Access Discussions

MSLs can present highly scientific, accurate, fair and objective data to Payors (Hospital Formulary Committees, Health Insurers, Health Technology Assessment Committees, etc) to provide them with objective information about Company products.

Pre- Approval Activities

MSLs can engage in interactions with Payors to raise awareness so that payors can plan and budget so that patients can receive the product when it becomes available. MSLs can organize Speakers training to prepare speakers for delivering presentations to other HCP when the Marketing Authorization is granted.

Provision ofscientific support to company Sales Representativesand other company representativesProvide medical and product training and scientific support to Sales Representatives in coordination with Training/Medical Affairs Department as appropriateAct as a reference point to Sales Representatives for any scientific query, in collaboration with Medical Information as appropriate.Local implementation of Medical Affairs Planin their areas:Support the set up and follow up of local company sponsored studies, registries and other non-interventional Medical Affairs studiesPropose investigators and sites for interventional and non-interventional Medical Affairs studies.Participate in investigator meetings preparation, recruitment follow-up and study result presentation.Receive investigator proposals for IIS and ensure they are discussed within the Medical Affairs department for decision.Through scientific interactions,gain valuable insightinto treatment patterns and scientific activities in the therapeutic area and provide input and a strategic view to the company Medical Affairs Plan / business decision-making.Observes and promotes all regulatory requirements as defined in applicable regulations, rules and procedures established by the Company, including but not limited toHealth Care Business Integrity and Pharmacovigilance.Follow principles, procedures and training included in SAFE Fleet program.GCO collaboration: Support GCO studies when needed through the identification of potential sites and facilitating a direct contact with leading specialists.Report all suspected adverse reactions, serious or non serious, I may be aware of within a maximum of 24 hours after being aware of it and communicate it to the Pharmacovigilance Department.

Additionally, for all employees involved in Research Related Activities (RRA):

Ensure safety reporting requirements (timely AE/PQC reporting) as set out in company policies and SOPs (Standard Operating Procedures) are met and appropriately managed when planning projects, developing materials, executing projects and contracting vendors.Ensure HCC and legal requirements (Fair Market Value, Transfer of Value rules, Promotional Materials rules) are fully understood, appropriately managed and complied with when planning projects, developing materials, executing projects and contracting vendors.Ensure inspection readiness with respect to personal training compliance, and availability of recent CV and individualized Job Description.

At Johnson Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/. 

For more than 130 years, diversity, equity inclusion (DEI) has been a part of our cultural fabric at Johnson Johnson and woven into how we do business every day. Rooted in Our Credo, the values of DEI fuel our pursuit to create a healthier, more equitable world. Our diverse workforce and culture of belonging accelerate innovation to solve the world’s most pressing healthcare challenges.

We know that the success of our business – and our ability to deliver meaningful solutions – depends on how well we understand and meet the diverse needs of the communities we serve. Which is why we foster a culture of inclusion and belonging where all perspectives, abilities and experiences are valued and our people can reach their potential.

At Johnson Johnson, we all belong.

To maximize company product value through high scientific quality communication with Leading Specialists on a peer-to-peer basis. Accordingly, to strategic lines of Medical Affairs Plan, the MSL is jointly responsible for achieving short-term and long-term company goals at local level.

To be a therapeutic area scientific expert, responsible for discussing our products, patients’ treatment trends and studies in the therapeutic areas in which we are involved, on a peer-to-peer basis with a defined audience of Leading Specialists (Physicians, Pharmacists, Hospital Managers, Board Members of Scientific Societies, and other stakeholders) and to be consideredan internal and external trusted scientific counterpart.

MSLs should have their own Activity Plan and personal objectives. The Individual Activity Plans must be based on the MSLs Country Activity Plan, which is aligned with the Medical Affairs Component of the relevant Brand Plans

To keep abreast ofmedical and scientific knowledge.Continuous update on products, patient’s treatment trends, clinical activities and studies conducted within the therapeutic area in their region.Development and maintenance of acontact network with Leading Specialists.Understand their needs, key value drivers, practical treatment patterns and scientific activities within therapeutic areaCommunicate value of company products, incl. clinical questionnaire discussionsThrough scientific interactions, communicate medical benefits of products and contribute to foster innovative approachesRepresent the company within professional associations in the therapeutic area in cooperation with Medical Affairs/ Medical Education and other positions in the Medical Affairs Department.Proactive and reactive communication of medical scientific data according to following criteriaProactive Scientific Communication to Leading Specialists must be consistent with the last approved Summary of Product Characteristics regarding the safe and effective use of approved products in approved indications. Content of Scientific Communication should be highly scientific, accurate, fair and objective, based on an up-to-date evaluation of all relevant evidence and reflect that evidence clearly, using neither marketing claims nor brand name.In some very specific circumstances, the MSL can interact proactively with non-Leading Specialists. The program should be clearly defined in the MSL Country Activity Plan, providing the rational, the objective, content, timelines and selection criteria of the HCPs to be involved.Description of RD programs and discussing regulatory developments with no promotional intent are also part of Scientific Communication.Reactive Communication of medical scientific data can be provided upon request to any Health Care Professional, within the approved label or off-label. The request should come either directly from the HCP or via the Medical Information department. MSLs are required to document all off-label information requests they receive from Leading Specialists and other HCPs that they may interact withOrganization and participation inMedical Education activities,at local /regional level:Identify/support/educate speakersBuild Medical Education programs with scientific third partyCollaborate with Medical Education manager in National Medical education activitiesProvide scientific material under request. MSLs may initiate discussion with potential speakers, discussing documents/ slides which may be of help for future presentations.Organization and participation inAdvisory Boards in cooperation with Medical Affairs/Medical Education/other positions in the Medical Affairs Department.Market Access Discussions

MSLs can present highly scientific, accurate, fair and objective data to Payors (Hospital Formulary Committees, Health Insurers, Health Technology Assessment Committees, etc) to provide them with objective information about Company products.

Pre- Approval Activities

MSLs can engage in interactions with Payors to raise awareness so that payors can plan and budget so that patients can receive the product when it becomes available. MSLs can organize Speakers training to prepare speakers for delivering presentations to other HCP when the Marketing Authorization is granted.

Provision ofscientific support to company Sales Representativesand other company representativesProvide medical and product training and scientific support to Sales Representatives in coordination with Training/Medical Affairs Department as appropriateAct as a reference point to Sales Representatives for any scientific query, in collaboration with Medical Information as appropriate.Local implementation of Medical Affairs Planin their areas:Support the set up and follow up of local company sponsored studies, registries and other non-interventional Medical Affairs studiesPropose investigators and sites for interventional and non-interventional Medical Affairs studies.Participate in investigator meetings preparation, recruitment follow-up and study result presentation.Receive investigator proposals for IIS and ensure they are discussed within the Medical Affairs department for decision.Through scientific interactions,gain valuable insightinto treatment patterns and scientific activities in the therapeutic area and provide input and a strategic view to the company Medical Affairs Plan / business decision-making.Observes and promotes all regulatory requirements as defined in applicable regulations, rules and procedures established by the Company, including but not limited toHealth Care Business Integrity and Pharmacovigilance.Follow principles, procedures and training included in SAFE Fleet program.GCO collaboration: Support GCO studies when needed through the identification of potential sites and facilitating a direct contact with leading specialists.Report all suspected adverse reactions, serious or non serious, I may be aware of within a maximum of 24 hours after being aware of it and communicate it to the Pharmacovigilance Department.

Additionally, for all employees involved in Research Related Activities (RRA):

Ensure safety reporting requirements (timely AE/PQC reporting) as set out in company policies and SOPs (Standard Operating Procedures) are met and appropriately managed when planning projects, developing materials, executing projects and contracting vendors.Ensure HCC and legal requirements (Fair Market Value, Transfer of Value rules, Promotional Materials rules) are fully understood, appropriately managed and complied with when planning projects, developing materials, executing projects and contracting vendors.Ensure inspection readiness with respect to personal training compliance, and availability of recent CV and individualized Job Description.Scientific degree: Medical Doctor, Pharmaceutical or Nature Science university degree, or related qualification (i.e. psychology degree)Deep knowledge of the therapeutic area, strength in research and interpretation of medical dataBackground to be accepted by the Leading Specialists in peer-to-peer relationship, i.e. relevant work experience, scientific acumen and/or communication skills.Highly customer focused with an awareness of the importance of business resultsInnovative with the ability to coordinate and drive a complex and changing environmentAwareness of, and adherence to, Johnson Johnson Credo values and International Health Care Business Integrity Guide.

Special Requirements

Deep scientific knowledge in the therapeutic areaScientific degree: Medical Doctor, Pharmaceutical or Nature Science university degree, or related qualification (i.e. psychology degree)Deep knowledge of the therapeutic area, strength in research and interpretation of medical dataBackground to be accepted by the Leading Specialists in peer-to-peer relationship, i.e. relevant work experience, scientific acumen and/or communication skills.Highly customer focused with an awareness of the importance of business resultsInnovative with the ability to coordinate and drive a complex and changing environmentAwareness of, and adherence to, Johnson Johnson Credo values and International Health Care Business Integrity Guide.

Special Requirements

Deep scientific knowledge in the therapeutic area